Provided by Tiger Fintech (Singapore) Pte. Ltd.

FOSUN PHARMA

15.480
+0.3402.25%
Volume:4.26M
Turnover:65.52M
Market Cap:41.24B
PE:16.14
High:15.500
Open:15.280
Low:15.220
Close:15.140
Loading ...

Chinese Regulator Approves Shanghai Fosun Pharmaceutical's Vaccine for Clinical Trials

MT Newswires Live
·
04 Mar

Fosun Pharmaceutical Secures Clinical Trial Approval for Colorectal Cancer Treatment

MT Newswires Live
·
28 Feb

Fosun Pharmaceutical Gets Marketing Authorization for Chronic Kidney Disease Drug

MT Newswires Live
·
27 Feb

Fosun Pharmaceutical Unit Gets Chinese Regulator's Nod for Chronic Kidney Disease Tablets

MT Newswires Live
·
26 Feb

Fosun Pharmaceutical Unit Gets China Nod for Lung Diseases Drug

MT Newswires Live
·
26 Feb

Fosun Pharmaceutical Unit Gets China Nod for Colon Cleansing Granules

MT Newswires Live
·
26 Feb

BRIEF-Shanghai Fosun Pharma's Unit Received Marketing Registration Approval From NMPA China For Compound Sodium Picosulfate Granules

Reuters
·
26 Feb

BRIEF-Anhui Sunhere Says Shareholder Shanghai Fosun Pharma To Unload Up To 3% Stake

Reuters
·
23 Feb

Anhui Sunhere Says Shareholder Shanghai Fosun Pharmaceutical Plans to Unload up to 3% Stake in Three Months

THOMSON REUTERS
·
23 Feb

Fosun Pharma Unit to Boost Stake in Medical Services Firm with Additional Investment

MT Newswires Live
·
21 Feb

Fosun Pharmaceutical Gets US FDA Approval for HLX99 Clinical Trials

MT Newswires Live
·
11 Feb

Chinese regulator Accepts New Drug Applications from Shanghai Fosun Pharmaceutical's Two Subsidiaries

MT Newswires Live
·
10 Feb

Fosun Pharma Unit Gets China Clinical Trial Approval for COPD Treatment

MT Newswires Live
·
07 Feb

Fosun Pharmaceutical Gains EU Marketing Approval for Lung Cancer Drug

MT Newswires Live
·
06 Feb

Shanghai Fosun Pharmaceutical Arm Gets Registration for Anti-Bronchospasm Drug in China

MT Newswires Live
·
24 Jan

Fosun Pharmaceutical to Repurchase Shares in Hong Kong, Shanghai

MT Newswires Live
·
23 Jan